Literature DB >> 21883671

Invasive group B streptococcal infections in adults, France (2007-2010).

A Tazi1, P C Morand, H Réglier-Poupet, N Dmytruk, A Billoët, D Antona, P Trieu-Cuot, C Poyart.   

Abstract

Group B streptococcus (GBS) has emerged as an important cause of invasive infection in adults. Here, we report the clinical and microbiological characteristics of 401 non-redundant GBS strains causing adult invasive infections collected during a 4-year period (2007-2010). Bacteraemia without focus (43.4%) and bone and joint infections (18.7%) were the main clinical manifestations. The distribution of capsular polysaccharide (CPS) type showed that types Ia, III, and V accounted for 71.8% of all strains. Resistance to erythromycin increased from 20.2% in 2007 to 35.3% in 2010, and was mainly associated with CPS type V harbouring the erm(B) resistant determinant.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883671     DOI: 10.1111/j.1469-0691.2011.03628.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  32 in total

1.  Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.

Authors:  S Kernéis; C Plainvert; J-P Barnier; A Tazi; N Dmytruk; B Gislain; J Loubinoux; F El Sayed; V Cattoir; N Desplaces; V Vernet; P Morand; C Poyart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-26       Impact factor: 3.267

2.  Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.

Authors:  Constantin Hays; Mathilde Louis; Céline Plainvert; Nicolas Dmytruk; Gérald Touak; Patrick Trieu-Cuot; Claire Poyart; Asmaa Tazi
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Molecular characterization of Streptococcus agalactiae isolates harboring small erm(T)-carrying plasmids.

Authors:  Fabrice Compain; Constantin Hays; Gérald Touak; Nicolas Dmytruk; Patrick Trieu-Cuot; Caroline Joubrel; Claire Poyart
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

4.  Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes.

Authors:  Anthony R Flores; Jessica Galloway-Peña; Pranoti Sahasrabhojane; Miguel Saldaña; Hui Yao; Xiaoping Su; Nadim J Ajami; Michael E Holder; Joseph F Petrosino; Erika Thompson; Immaculada Margarit Y Ros; Roberto Rosini; Guido Grandi; Nicola Horstmann; Sarah Teatero; Allison McGeer; Nahuel Fittipaldi; Rino Rappuoli; Carol J Baker; Samuel A Shelburne
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

5.  Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population.

Authors:  Roberto Rosini; Edmondo Campisi; Matteo De Chiara; Hervé Tettelin; Daniela Rinaudo; Chiara Toniolo; Matteo Metruccio; Silvia Guidotti; Uffe B Skov Sørensen; Mogens Kilian; Mario Ramirez; Robert Janulczyk; Claudio Donati; Guido Grandi; Immaculada Margarit
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

6.  Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Masami Toyama; Kouji Kimura; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

7.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

8.  Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections.

Authors:  Anne Six; Arnaud Firon; Céline Plainvert; Camille Caplain; Abdelouhab Bouaboud; Gérald Touak; Nicolas Dmytruk; Magalie Longo; Franck Letourneur; Agnès Fouet; Patrick Trieu-Cuot; Claire Poyart
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

Review 9.  Group B Streptococcus vaccine: state of the art.

Authors:  Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal:  Ther Adv Vaccines       Date:  2015-05

10.  Streptococcus agalactiae infection in cancer patients: a five-year study.

Authors:  B A S Pimentel; C A S Martins; J C Mendonça; P S D Miranda; G F Sanches; A L Mattos-Guaraldi; P E Nagao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.